Robert Brown, MD
Dermatology · Fayetteville, ARNPI 1396784443
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.0% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 41.3% of the total. Reporting peaked in 2019 at $617 and has fallen 85.8% since, to $88 in 2025. That places this record below the midpoint for dermatology clinicians in AR, where the typical reported total is $3,769.
Across 143 payments — averaging $17.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novartis$365
- Lilly USA, LLC$303
- Johnson & Johnson$202
- Sun Pharmaceutical Industries Inc.$135
- Sanofi$72
- plus $350 from 12 others
What the payments were for
- Food & beverage$2,26393%
- Education$1707%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 74 | $1,005 |
| Novartis | 21 | $365 |
| Lilly USA, LLC | 18 | $303 |
| Johnson & Johnson | 4 | $202 |
| Sun Pharmaceutical Industries Inc. | 3 | $135 |
| Sanofi | 4 | $72 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| E.r. Squibb & Sons, L.L.C. | 2 | $52 |
| Genentech USA, Inc. | 3 | $45 |
| Kyowa Kirin, Inc. | 3 | $41 |
| Mayne Pharma Commercial LLC | 1 | $25 |
| Janssen Scientific Affairs, LLC | 1 | $23 |
| Incyte Corporation | 1 | $22 |
| Amgen | 1 | $22 |
| Boehringer Ingelheim | 1 | $19 |
| Dermira, Inc. | 1 | $16 |
| UCB, Inc. | 1 | $13 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $13 |
How this compares
$2,433 in reported general payments places this provider in the 40th percentile of 75 dermatology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 16 | $107,858 |
| Dupixent PenDupilumab | 22 | $81,449 |
| Clobetasol Propionate | 71 | $4,469 |
| Metronidazole | 44 | $2,742 |
| Ketoconazole | 171 | $2,613 |
| Fluorouracil | 29 | $2,007 |
| Betamethasone Dipropionate | 39 | $1,894 |
| Tacrolimus | 19 | $1,347 |
| Triamcinolone Acetonide | 99 | $842 |
| Hydroxychloroquine Sulfate | 35 | $743 |
| Doxycycline Hyclate | 37 | $677 |
| Clindamycin Phosphate | 25 | $631 |
| Econazole Nitrate | 23 | $466 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 27 | $458 |
| Hydrocortisone | 110 | $451 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Fayetteville
- Scott JacksonFayetteville$533K
- Lance HenryFayetteville$39K
- Rebekah BaltzFayetteville$8K
- Christopher SchachFayetteville$5K
- Eric StewartFayetteville$5K
- Jamie AbbottFayetteville$4K
- Linsey LindleyFayetteville$1K
- Kevin St ClairFayetteville$822
- Sandra JohnsonFort Smith$543K
- Mildred CliftonBentonville$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.